Loading...
XNYS
PHG
Market cap20bUSD
Apr 04, Last price  
22.00USD
1D
-7.46%
1Q
-12.24%
Jan 2017
-27.77%
IPO
-11.82%
Name

Koninklijke Philips NV

Chart & Performance

D1W1MN
P/E
—
P/S
1.03
EPS
—
Div Yield, %
4.29%
Shrs. gr., 5y
-0.82%
Rev. gr., 5y
-1.55%
Revenues
18.02b
-0.81%
30,371,519,32026,976,037,07026,835,349,62026,385,000,00023,189,000,00025,419,000,00022,579,000,00024,788,000,00023,329,000,00021,391,000,00024,244,000,00024,516,000,00017,780,000,00018,121,000,00019,482,000,00019,535,000,00017,156,000,00017,827,000,00018,169,000,00018,021,000,000
Net income
-702m
L+50.64%
2,866,432,4505,383,387,4504,174,890,690-92,000,000410,000,0001,446,000,000-1,295,000,000226,000,0001,169,000,000415,000,000645,000,0001,448,000,0001,657,000,0001,090,000,0001,168,000,0001,187,000,000612,000,000-1,618,000,000-466,000,000-702,000,000
CFO
1.57b
-30.54%
2,088,822,940853,916,6301,368,310,6501,495,000,0001,545,000,0002,156,000,000566,000,0002,198,000,0001,138,000,0001,303,000,0001,167,000,0001,904,000,0001,870,000,0001,780,000,0002,031,000,0002,777,000,0001,629,000,000-173,000,0002,259,000,0001,569,000,000
Dividend
May 13, 20250.88604 USD/sh
Earnings
Apr 28, 2025

Profile

Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
URL
https://www.philips.com/
IPO date
Sep 18, 2009
Employees
71,519
Domiciled in
NL
Incorporated in
NL

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
18,021,000
-0.81%
18,169,000
1.92%
17,827,000
3.91%
Cost of revenue
17,063,000
17,743,000
18,016,000
Unusual Expense (Income)
NOPBT
958,000
426,000
(189,000)
NOPBT Margin
5.32%
2.34%
Operating Taxes
963,000
(73,000)
(113,000)
Tax Rate
100.52%
NOPAT
(5,000)
499,000
(76,000)
Net income
(702,000)
50.64%
(466,000)
-71.20%
(1,618,000)
-364.38%
Dividends
(1,000)
(2,000)
(412,000)
Dividend yield
0.00%
0.01%
3.34%
Proceeds from repurchase of equity
(411,000)
(662,000)
(175,000)
BB yield
1.74%
3.39%
1.42%
Debt
Debt current
443,000
652,000
931,000
Long-term debt
8,121,000
7,823,000
8,352,000
Deferred revenue
431,000
515,000
Other long-term liabilities
1,229,000
2,099,000
1,595,000
Net debt
5,272,000
5,603,000
6,903,000
Cash flow
Cash from operating activities
1,569,000
2,259,000
(173,000)
CAPEX
(676,000)
(345,000)
(806,000)
Cash from investing activities
(573,000)
(636,000)
(1,487,000)
Cash from financing activities
(496,000)
(848,000)
500,000
FCF
566,000
1,882,000
(922,000)
Balance
Cash
2,403,000
1,872,000
1,183,000
Long term investments
889,000
1,000,000
1,197,000
Excess cash
2,390,950
1,963,550
1,488,650
Stockholders' equity
5,800,000
6,496,000
8,532,000
Invested Capital
18,803,050
19,807,450
22,065,350
ROIC
2.38%
ROCE
4.50%
1.96%
EV
Common stock shares outstanding
933,371
925,238
881,616
Price
25.32
20.11%
21.08
50.53%
14.00
-62.00%
Market cap
23,632,949
21.17%
19,504,024
57.98%
12,346,149
-64.74%
EV
28,941,949
25,140,024
19,283,149
EBITDA
2,347,000
1,603,000
1,413,000
EV/EBITDA
12.33
15.68
13.65
Interest
337,000
306,000
258,000
Interest/NOPBT
35.18%
71.83%